Acceptance and Adherence of Oral Endocrine Therapy in Women with Metastatic Breast Cancer: Exacampania Group Study-Reference-Cited by-同舟云学术

Acceptance and Adherence of Oral Endocrine Therapy in Women with Metastatic Breast Cancer: Exacampania Group Study

Published:2015-03-19 Issue:3 Volume:21 Page:326-328
ISSN:1075-122X
Container-title:The Breast Journal
language:en
Short-container-title:Breast J

Author:

Addeo Raffaele¹,Iodice Patrizia¹,Maiorino Luigi²,Febbraro Antonio³,Incoronato Pasquale⁴,Pisano Agata⁵,Bianco Maddalena⁶,Mabilia Roberto⁷,Riccardi Ferdinando⁸,Del Prete Salvatore¹

Affiliation:

1. U.O. Oncologia; ASL NA2 NORD; Frattamaggiore Italy

2. U.O. Oncologia; SAN GENNARO HOSPITAL; Napoli Italy

3. U.O. Oncologia; FATEBENEFRATELLI HOSPITAL; Benevento Italy

4. U.O. Oncologia; ASLNA2 NORD; Giugliano (NA) Italy

5. U.O. Oncologia; ASLNA2 NORD; Pozzuoli (NA) Italy

6. U.O. Oncologia; ASLNA3SUD; Gragnano Italy

7. U.O. Oncologia; ASLNA2 NORD; Ischia Italy

8. U.O. Oncologia; AORN Cardarelli; Napoli Italy

Publisher

Hindawi Limited

Subject

Oncology,Surgery,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tbj.12409/fullpdf

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring adherence in patients with advanced breast cancer: focus on CDK4/6 inhibitors;Acta Pharmaceutica;2023-12-01

2. Satisfaction of Cancer Patients Treated with Oral Anticancer Medications regarding Dispensing by Community Pharmacists: A Cross-Sectional Study;European Journal of Cancer Care;2023-08-29

3. Endocrine Treatment for Breast Cancer Patients Revisited—History, Standard of Care, and Possibilities of Improvement;Cancers;2021-11-11

4. Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study;BMC Cancer;2019-06-21

5. Adherence and safety of regorafenib for patients with metastatic colorectal cancer: observational real-life study;Future Oncology;2017-02